{"title":"绝经后出血及其诊断价值的临床研究综述","authors":"Kanika Chopra","doi":"10.15406/mojwh.2019.08.00213","DOIUrl":null,"url":null,"abstract":"Postmenopausal bleeding refers to any uterine bleeding in a menopausal woman, accounting to nearly 5 % of all outpatient visits to a gynaecologist.1 Among the 454 postmenopausal patients in one of the study, final diagnosis was cancer in 6.6% cases, atypical hyperplasia in 0.2%, hyperplasia without atypia in 2%, polyps in 37.7%, fibroid in 6.2%, proliferative/secretory in 14.5% and hypertrophy/atrophy in 30.8% cases.2 The causes of postmenopausal bleeding can be gynaecological or nongynaecological. Among the gynaecological causes it can be either intrauterine or extrauterine and these includes cervical, vaginal, vulval, or from fallopian tube and ovaries. Bleeding from urethra, bladder, anus, rectum, bowel or perineum should also be ruled out.","PeriodicalId":47398,"journal":{"name":"Womens Health","volume":"1 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical perspective to postmenopausal bleeding and its diagnostic evaluation: a mini review\",\"authors\":\"Kanika Chopra\",\"doi\":\"10.15406/mojwh.2019.08.00213\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Postmenopausal bleeding refers to any uterine bleeding in a menopausal woman, accounting to nearly 5 % of all outpatient visits to a gynaecologist.1 Among the 454 postmenopausal patients in one of the study, final diagnosis was cancer in 6.6% cases, atypical hyperplasia in 0.2%, hyperplasia without atypia in 2%, polyps in 37.7%, fibroid in 6.2%, proliferative/secretory in 14.5% and hypertrophy/atrophy in 30.8% cases.2 The causes of postmenopausal bleeding can be gynaecological or nongynaecological. Among the gynaecological causes it can be either intrauterine or extrauterine and these includes cervical, vaginal, vulval, or from fallopian tube and ovaries. Bleeding from urethra, bladder, anus, rectum, bowel or perineum should also be ruled out.\",\"PeriodicalId\":47398,\"journal\":{\"name\":\"Womens Health\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Womens Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.15406/mojwh.2019.08.00213\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Womens Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15406/mojwh.2019.08.00213","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Clinical perspective to postmenopausal bleeding and its diagnostic evaluation: a mini review
Postmenopausal bleeding refers to any uterine bleeding in a menopausal woman, accounting to nearly 5 % of all outpatient visits to a gynaecologist.1 Among the 454 postmenopausal patients in one of the study, final diagnosis was cancer in 6.6% cases, atypical hyperplasia in 0.2%, hyperplasia without atypia in 2%, polyps in 37.7%, fibroid in 6.2%, proliferative/secretory in 14.5% and hypertrophy/atrophy in 30.8% cases.2 The causes of postmenopausal bleeding can be gynaecological or nongynaecological. Among the gynaecological causes it can be either intrauterine or extrauterine and these includes cervical, vaginal, vulval, or from fallopian tube and ovaries. Bleeding from urethra, bladder, anus, rectum, bowel or perineum should also be ruled out.
期刊介绍:
For many diseases, women’s physiology and life-cycle hormonal changes demand important consideration when determining healthcare management options. Age- and gender-related factors can directly affect treatment outcomes, and differences between the clinical management of, say, an adolescent female and that in a pre- or postmenopausal patient may be either subtle or profound. At the same time, there are certain conditions that are far more prevalent in women than men, and these may require special attention. Furthermore, in an increasingly aged population in which women demonstrate a greater life-expectancy.